Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05159765Not ApplicableActive Not Recruiting

Progressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial

Role: lead

NCT06475053Not ApplicableActive Not Recruiting

Visual Performance of Center Distance Daily Disposable Multifocal Lenses

Role: lead

NCT05495971Not ApplicableCompleted

Extended Depth of Focus Contact Lenses for Presbyopia

Role: lead

NCT03358862Unknown

Myopia Progression With a Novel Extended Depth of Focus Contact Lens

Role: collaborator

All 4 trials loaded